United Community Banks, Inc. will release its second quarter 2026 financial results on Tuesday, July 21, 2026, before the stock market opens. The company will also hold a conference call at 9:00 a.m. EDT on the same day to discuss its financial results, business highlights, and outlook. The announcement provides investors with an opportunity to review the bank's performance and future strategies.

Participants can pre-register for the conference call by visiting the provided registration link. Those without internet access or unable to pre-register may dial in by calling 1-844-676-1337. The call will also be webcast live and accessible via the "Events and Presentations" section under "News and Events" on the company's investor relations website at ucbi.com.

United Community Banks, Inc. is the financial holding company for United Community, a top-100 U.S. financial institution. As of March 31, 2026, the company had $28.2 billion in assets and operated 200 offices across Alabama, Florida, Georgia, North Carolina, South Carolina, and Tennessee. It offers a full range of banking, mortgage, and wealth management services, along with a nationally recognized SBA lending franchise and an equipment finance subsidiary.

The company has received multiple accolades, including being named the most awarded bank in the Southeast for Retail Banking Customer Satisfaction by J.D. Power. It has also been recognized as one of the "Best Banks to Work For" by American Banker for nine consecutive years and earned 2026 Greenwich Best Bank awards for Small Business Banking. Forbes has consistently ranked United Community among the World’s Best and America’s Best Banks.

For further information, investors can contact Elizabeth Boggess, Head of Investor Relations, at (864) 241-8705 or via email at Investor_Relations@ucbi.com .

Piper Sandler analyst Stephen Scouten maintains United Community Banks with a Neutral rating and lowered the price target to $35 from $36. The adjustment reflects a revised valuation outlook for the stock.

Rating and Target Details

The research note confirms the Neutral stance while adjusting the price objective downward. The new target of $35 compares to the previous estimate of $36.